Variables | Control group n = 15 | PED group n = 14 | DLD group n = 21 | FLD group n = 58 | ANOVA-P value (Kruskal–Wallis test) |
---|---|---|---|---|---|
Age (years) | 54 ± 14 | 59 (52, 68) | 67 (55, 71) | 65 (54, 75) | 0.083 |
Sex (female/male) | 6/9 | 10/4 | 9/12 | 21/37 | N/A |
APACHE II score | 14 ± 5 | 15 (10, 17) | 20 (15, 28)a, b | 18 (14, 25)a, b | 0.01 |
HR (bpm) | 78 (65, 93) | 87 (78, 93) | 85 (80, 97) | 94 (84, 103)a | 0.019 |
MAP (mmHg) | 87 ± 9 | 85 ± 10 | 84 ± 9 | 83 ± 12 | 0.336 |
FiO2 (%) | 30 (30, 35) | 45 (40, 80)a | 40 (33, 58)a | 40 (35, 75)a | < 0.0001 |
PaO2/FiO2 (mmHg) | 390 (347, 474) | 156 (86, 209)a | 210 (117, 244)a | 236 (170, 290)a, b | < 0.0001 |
d-Dimer (mg/L FEU) | 1.0 (0.5, 3.0) | 4.1 (2.7, 4.9) | 4.6 (1.6, 6.2) | 5.5 (1.9, 12.4)a | 0.014 |
NE dose (μg/kg min) | 0.00 (0.00, 0.09) | 0.08 (0.00, 0.39)a | 0.02 (0.00, 0.23) | 0.08 (0.00, 0.26) | 0.237 |
28-day mortality | 0/15 | 4/14 | 3/21 | 11/58 | N/A |